| Model: | Ratio |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.0088 | 30.97 | 31388 | |||
| XBI | SPDR® S&P Biotech ETF | 0 | 136.45 | 9884769 |
| Entry Threshold: | 0.20 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Simple | Reversals: | |
| Inverted: | IDNA | Transformed: | IDNA | A=1000.0 B=0.1 | |
| MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
| RSI Period: | 6 | RSI Threshold: | 15 | ||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | 12974.03 |
| Total net P/L: | 2974.03 | Total ROI: | 29.74 % |
| CAGR: | 462.87 % | Max. DD: | 7.60 % |
| System Score: | 387.514 | Sharpe Ratio: | 2.105 |
| Start Date: | 2025-01-02 | End Date: | 2025-02-26 |
| Total days: | 55 | ||
| Commissions: | 57.16 | Comm.% P/L | 1.89 % |
| Total Transactions: | 32 | Log. Linearity: | 94.249 % |
| Total | Long |
Short |
IDNA | XBI | |
|---|---|---|---|---|---|
| Total Profit/Loss | 3031.19 | 2571.13 | 460.06 | 1426.16 | 1605.03 |
| Total Profit | 3205.23 | 2571.13 | 634.10 | 1579.93 | 1673.10 |
| Total Loss | 174.04 | 0.00 | 174.04 | 153.77 | 68.07 |
| Profit Factor | 18.42 | 0.00 | 3.64 | 10.27 | 24.58 |
| Trades | 8 | 4 | 4 | 8 | 8 |
| Winning Trades | 6 | 4 | 2 | 5 | 6 |
| Losing Trades | 2 | 0 | 2 | 2 | 2 |
| % Profitable | 75.00 | 100.00 | 50.00 | 62.00 | 75.00 |
| Profit/Loss Per Trade % | 3.37 | 5.82 | 0.97 | 1.61 | 1.78 |
| Profit Per Trade % | 4.75 | 5.82 | 2.64 | 2.84 | 2.47 |
| Loss Per Trade % | 0.66 | 0.00 | 0.66 | 0.62 | 0.26 |
| Days In Trade | 34 | 20 | 14 | 34 | 34 |
| Days In Trade (Avg. Per Trade) | 4.25 | 5.00 | 3.50 | 4.25 | 4.25 |
| % Days In Trade | 61.82 | 36.36 | 25.45 | 61.82 | 61.82 |